In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
After finishing at $9.76 in the prior trading day, Ginkgo Bioworks Holdings Inc (NYSE: DNA) closed at $10.13, up 3.79%. In other words, the price has increased by $3.79 from its previous closing price. On the day, 1.55 million shares were traded. DNA stock price reached its highest trading level at $10.4397 during the session, while it also had its lowest trading level at $9.78.
Ratios:
Our goal is to gain a better understanding of DNA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.88 and its Current Ratio is at 4.88. In the meantime, Its Debt-to-Equity ratio is 0.67 whereas as Long-Term Debt/Eq ratio is at 0.67.
Raymond James Downgraded its Outperform to Mkt Perform on November 14, 2023, whereas the target price for the stock was revised from $3.50 to $2.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 17 ’25 when Dmytruk Mark E. bought 640 shares for $9.84 per share.
Che Austin bought 2,200 shares of DNA for $24,596 on Jul 09 ’25. On Jun 23 ’25, another insider, Che Austin, who serves as the Officer of the company, bought 99 shares for $8.43 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNA now has a Market Capitalization of 592928128 and an Enterprise Value of 576122624. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.50 while its Price-to-Book (P/B) ratio in mrq is 0.81. Its current Enterprise Value per Revenue stands at 2.427 whereas that against EBITDA is -1.772.
Stock Price History:
The Beta on a monthly basis for DNA is 1.49, which has changed by -0.11451048 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, DNA has reached a high of $16.85, while it has fallen to a 52-week low of $5.00. The 50-Day Moving Average of the stock is 14.56%, while the 200-Day Moving Average is calculated to be 13.30%.
Shares Statistics:
The stock has traded on average 1.26M shares per day over the past 3-months and 1283030 shares per day over the last 10 days, according to various share statistics. A total of 43.08M shares are outstanding, with a floating share count of 38.16M. Insiders hold about 31.28% of the company’s shares, while institutions hold 56.95% stake in the company. Shares short for DNA as of 1749772800 were 11312529 with a Short Ratio of 9.51, compared to 1747267200 on 11493376. Therefore, it implies a Short% of Shares Outstanding of 11312529 and a Short% of Float of 25.069999999999997.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
